How urine analysis reflects oxidative stress - Nitrotyrosine as a potential marker

Clinica Chimica Acta

Volumn 297, Issue 1-2, 2000, Pages 207-216

  Schwemmer, M ^a   Fink, B ^a   Kockerbauer R ^a   Bassenge, E ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Nitration; Reactive nitrogen species; Reactive oxygen species; Superoxide dismutase

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; ASCORBIC ACID; BIOLOGICAL MARKER; GLYCERYL TRINITRATE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; TYROSINE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NITRATION; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADULT; ASCORBIC ACID; BIOLOGICAL MARKERS; CHROMATOGRAPHY, GAS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; OXIDATIVE STRESS; REFERENCE VALUES; TYROSINE; URINALYSIS;

EID: 0034035265     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00247-3     Document Type: Article

References (32)

1. Kojda G., Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure [Review]. Cardiovasc Res. 43:1999;562-571.
2. Miller F.J.J., Gutterman D.D., Rios C.D., et al. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 82:1998;1298-1305.
3. Leeuwenburgh C., Hardy M.M., Hazen S.L., et al. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem. 272:1997;1433-1436.
4. Moriel P., Abdalla D.S. Nitrotyrosine bound to beta-VLDL-apoproteins: a biomarker of peroxynitrite formation in experimental atherosclerosis. Biochem Biophys Res Commun. 232:1997;332-335.
5. Langenstroer P., Pieper G.I.A. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol. 263:1992;H257-H265.
6. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350:1994;9-12.
7. Liu P., Hock C.E., Nagele R., et al. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol. 272:1997;H2327-H2336.
8. Bassenge E., Fink B., Schvremmer M. Oxidative stress, vascular dysfunction and heart failure. Heart Failure Rev. 4:1999;133-145.
9. Bruijn L.I., Beal M.F., Becher M.W., et al. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci USA. 94:1997;7606-7611.
10. Van der Vliet A., Eiserich J.P., O'Neill C.A., et al. Tyrosine modification by reactive nitrogen species: a closer look. Arch Biochem Biophys. 319:1995;341-349.
11. Ischiropoulos H., Zhu L., Clien J., et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys. 298:1992;431-437.
12. Yamakura F., Taka H., Fujimura T., et al. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem. 273:1998;14085-14089.
13. Szabo C., Zingarelli B., Salzman A.L. Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite. Circ Res. 78:1996;E1051-E1053.
14. Ischiropoulos H., al-Mehdi A.B. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 364:1995;279-282.
15. Dikalov S., Fink B., Skatchkov M., et al. Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C. Free Radic Biol Med. 27:(I1/2):1999;170-176.
16. Bassenge E., Fink B. Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state. Naunyn Schmiedeberg's Arch Pharmacol. 353:1996;363-367.
17. Tabrizi-Fard M.A., Maurer S., Fung H.L. In vivo disposition of 3-nitro-L-tyrosine in rats: implications on tracking systemic peroxynitrite exposure. Drug Metab Dispos. 27:1999;429-431.
18. Herce-Pagliai C., Kotecha S., Shuker D.E. Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: a review. Nitric Oxide. 2:1998;324-336.
19. Khan J., Brennan D.M., Brailey N., et al. 3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J. 330:1998;795-801.
20. Bassenge E., Fink N., Skatchkov M., et al. Dietary supplement with vitamin C prevents nitrate tolerance. J Clin Invest. 102:1998;67-71.
21. Dikalov S., Fink B., Skatchkov M., et al. Formation of reactive oxygen species by PETN and GTN in vitro and development of nitrate tolerance. J Pharmacol Exp Ther. 286:1998;938-944.
22. Schwedhelm E., Tsikas D., Gutzki F.-M., Frölich J.C. Gas chromatographic-tandem mass spectrometric quantification of free 3-nitrotyrosine in human plasma at the basal state. Anal Biochem. 276:2000;195-203.
23. Ohshima H., Celan I., Chazotte L., et al. Analysis of 3-nitrotyrosine in biological fluids and protein hydrolyzates by high-performance liquid chromatography using a postseparation, on-line reduction column and electrochemical detection: results with various nitrating agents. Nitric Oxide. 3:1999;132-141.
24. Ohshima H., Friesen M., Brouet I., et al. Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem Toxicol. 28:(9):1990;647-652.
25. Uttenthal L.O., Alonso D., Farnandez A.P., et al. Neuronal and inducible nitric oxide synthase and nitrotyrosine immunoreactivities in the cerebral cortex of the aging rat. Microsc Res Tech. 43:1998;75-88.
26. Schmidt H.H.H.W., Angerer O., Hugel S., et al. Ischemia/reperfusion and peroxynitrite. Basic Res Cardiol. 94:1999;410.
27. Chen L.Y., Mehta P.P., Mehta J.L., et al. Platelet inhibitory effect of nitroglycerin in platelet-rich plasma: relevance of glutathione-S-transferases in plasma. Sustained antiplatelet properties of nitroglycerin during hemodynamic tolerance in rats. J Invest Med. 28:1996;432-438.
28. Chong S., Fung H.L. Biochemical and pharmacological interactions between nitroglycerin and thiols - effects of thiol structure on nitric oxide generation and tolerance reversal. Biochem Pharmacol. 42:1991;1433-1439.
29. Chong S., Fung H.L. Effects of thiol structure on nitric oxide generation and tolerance reversal. Biochem Pharmacol. 42:1991;1433-1439.
30. Goldstein S., Czapski G. Mechanism of the nitrosation of thiols and amines by oxygenated NO solutions: the nature of the nitrosating intermediates. J Am Chem Soc. 118:1996;3419-3425.
31. Goldstein S., Squadrito G.L., Pryor W.A., et al. Direct and indirect oxidations by peroxynitrite, neither involving the hydroxyl radical. Free Radic Biol Med. 21:1996;965-974.
32. Silbernagl S. Tubular transport of amino acids and small peptides. Handbook of Physiology - Renal Physiology. 2:1992;1937-1976 Oxford University Press/Am. Phys. Soc, New York/Oxford.